We are live on
!
Find out more
GC
Gullane Capital Portfolio holdings
AUM
$37.4M
1-Year Est. Return
112.18%
This Fund
S&P 500
This Quarter
Est. Return
-18.7%
1 Year Est. Return
+112.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$37.4M
AUM Growth
-$25.3M
(-40%)
Cap. Flow
-$15.1M
Cap. Flow
% of AUM
-40.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Scientific Inc Tranche 1 Warrants
CORZW
|
+$696K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Scientific
CORZ
|
+$15.4M |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$225K |
| 3 |
Core Scientific Inc Tranche 2 Warrants
CORZZ
|
+$73K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 96.63% |
| 2 | Communication Services | 0% |
Similar funds
CI
RH
ICP
BAM
FC
VMC
SPIG
IVAI
Gullane Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Gullane Capital held 7 positions worth $37.4M, down 40% from $62.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Gullane Capital withdrew a net $15.1M in Q4 2025, closing 2 positions and reducing 3 holdings. Its most notable exit was Nebius Group N.V., an estimated $225K position sold in full.
By sector, the portfolio is most concentrated in Technology at 97% of assets, up from 96% a quarter earlier, followed by Communication Services.
Against the trend, Gullane Capital added an estimated $696K to Core Scientific Inc Tranche 1 Warrants.
- Gullane Capital added most to Core Scientific Inc Tranche 1 Warrants in Q4 2025, an estimated $696K increase.
- Gullane Capital's biggest Q4 2025 reduction was Core Scientific, cutting an estimated $15.4M.
- Gullane Capital fully exited Nebius Group N.V. in Q4 2025, selling an estimated $225K.
- Gullane Capital's ten largest holdings make up 100% of its $37.4M portfolio in Q4 2025.
- Gullane Capital opened 0 new positions and closed 2 in Q4 2025.
- Gullane Capital's portfolio value fell 40% quarter-over-quarter to $37.4M.
Based on Gullane Capital's 13F filing for Q4 2025, filed 17 Feb 2026.